Tick Insights

Search Icon

Menu Toggle Icon

Skip to content
  • Home
  • Forex
  • CFD Indices
  • CFD Equities
  • Education
  • Events
Tick Insights

Tag: Bristol-Myers Squibb

CFD Trading – Buy Bristol-Myers SQ (BMY.NYS) @ $78.95. Stop @ $76.60 and Target @ $85.50.

June 27, 2022Nicholas

Bristol-Myers SQ Stock Code BMY.NYS

Outlook

Price broke and closed above a previous 52-week high in the previous trading session.… Read More

CFD Equities Bristol-Myers Squibb, CFD US Trading Note Leave a comment

CFD Trading 28 May 2019

May 28, 2019June 6, 2019Nicholas

General Electric Company Stock Code GE.NYS

Outlook

Price is currently inside the cloud but it is almost at the edge of the cloud.… Read More

CFD Equities Bristol-Myers Squibb, General Electric Leave a comment

CFD Trading 1 April 2019

April 1, 2019June 6, 2019Nicholas

Bristol-Myers Squibb Co Stock Code BMY.NYS

Outlook

Price declined below the cloud after both Conversion and Base lines had a bearish crossover earlier, confirming the downtrend in progress.… Read More

CFD Equities Bristol-Myers Squibb, Seagate Technology Leave a comment

About Us

Tick Insights

UTRADE

Upcoming Webinar

US & HK ETF Available For CFD Trade

Stay Connected

Subscribe to this blog and receive notifications of new posts by email.

Like our Facebook page for the latest updates!

 SG UTRADE

Recent Posts

  • Forex Trading Idea USD/CAD
  • CFD Trading – Buy Sunny Optical (2382.HKE) at $129.70. Stop at $110.90 and Target at $158.40
  • CFD Trading – Buy Xinyi Glass (868.HKE) at $18.58. Stop at $17.50 and Target at $20.93
  • FX Commentary – US Dollar Slipped As Traders Bet Inflation May Have Peaked.
  • CFD Trading – Buy Bristol-Myers SQ (BMY.NYS) @ $78.95. Stop @ $76.60 and Target @ $85.50.

Archives

Disclaimer

This information is prepared by personnel in UOB Kay Hian’s Alternative Products Department and is not the product of UOB Kay Hian’s Research Department. It is not a research report and is not intended as such, although a UOB Kay Hian Research report may be referenced as a link or as an attachment hereto.

Opinions expressed herein may differ from the opinions expressed by other areas of UOB Kay Hian, including research. This commentary is provided for information only. Neither the information nor any views expressed constitutes a solicitation for the purchase or sale of any securities or other financial instruments. It is not a personal recommendation, offer or solicitation to buy or sell.

Scroll to Top
 

Loading Comments...